Literature DB >> 17541342

Guidelines for the diagnosis of uncomplicated cirrhosis.

Hélène Fontaine1, Karine Petitprez, Françoise Roudot-Thoraval, Jean-Claude Trinchet.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17541342

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN： 0399-8320


× No keyword cloud information.
  13 in total

1.  FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virus.

Authors:  Keyur Patel; Mireen Friedrich-Rust; Yoav Lurie; Mircea Grigorescu; Carol Stanciu; Chuan-Mo Lee; Eugene R Schiff; Dieter Häussinger; Michael P Manns; Guido Gerken; Isabelle Colle; Michael Torbenson; Erik Pulkstenis; G Mani Subramanian; John G McHutchison; Stefan Zeuzem
Journal:  World J Gastroenterol       Date:  2011-11-07       Impact factor: 5.742

2.  Prognostic value of liver fibrosis biomarkers: a meta-analysis.

Authors:  Thierry Poynard; Yen Ngo; Hugo Perazzo; Mona Munteanu; Pascal Lebray; Joseph Moussalli; Dominique Thabut; Yves Benhamou; Vlad Ratziu
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-07

3.  Prediction of compensated liver cirrhosis by ultrasonography and routine blood tests in patients with chronic viral hepatitis.

Authors:  Hong Sub Lee; Jai Keun Kim; Jae Youn Cheong; Eun Jin Han; So Yeon An; Jun Ha Song; Yun Jung Jung; Sung Chan Jeon; Min Wook Jung; Eun Jung Jang; Sung Won Cho
Journal:  Korean J Hepatol       Date:  2010-12

4.  Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patients.

Authors:  Cédric Laouénan; Patrick Marcellin; Martine Lapalus; Feryel Khelifa-Mouri; Nathalie Boyer; Fabien Zoulim; Lawrence Serfaty; Jean-Pierre Bronowicki; Michelle Martinot-Peignoux; Olivier Lada; Tarik Asselah; Céline Dorival; Christophe Hézode; Fabrice Carrat; Florence Nicot; Gilles Peytavin; France Mentré; Jeremie Guedj
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

Review 5.  Systematic review of the literature on comparative effectiveness of antiviral treatments for chronic hepatitis B infection.

Authors:  Tatyana A Shamliyan; James R Johnson; Roderick MacDonald; Aasma Shaukat; Jian-Min Yuan; Robert L Kane; Timothy J Wilt
Journal:  J Gen Intern Med       Date:  2011-01-04       Impact factor: 5.128

6.  Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.

Authors:  Thierry Poynard; Yen Ngo; Mona Munteanu; Dominique Thabut; Vlad Ratziu
Journal:  Curr Hepat Rep       Date:  2011-03-01

7.  Liver stiffness measurements in patients with HBV vs HCV chronic hepatitis: a comparative study.

Authors:  Ioan Sporea; Roxana Sirli; Alexandra Deleanu; Adriana Tudora; Alina Popescu; Manuela Curescu; Simona Bota
Journal:  World J Gastroenterol       Date:  2010-10-14       Impact factor: 5.742

8.  Enhanced liver fibrosis test using ELISA assay accurately discriminates advanced stage of liver fibrosis as determined by transient elastography fibroscan in treatment naïve chronic HCV patients.

Authors:  Dalia Omran; Ayman Yosry; Samar K Darweesh; Mohammed M Nabeel; Mohammed El-Beshlawey; Sameh Saif; Azza Fared; Mohamed Hassany; Rania A Zayed
Journal:  Clin Exp Med       Date:  2017-05-31       Impact factor: 3.984

Review 9.  Role of liver biopsy in the era of direct-acting antivirals.

Authors:  Humberto C Gonzalez; Syed Mohammed Jafri; Stuart C Gordon
Journal:  Curr Gastroenterol Rep       Date:  2013-02

10.  Discordance between liver biopsy and FibroTest in assessing liver fibrosis in chronic hepatitis B.

Authors:  Mi Sung Park; Beom Kyung Kim; Jae Yoeun Cheong; Dong Joon Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Kwang-Hyub Han; Chae Yoon Chon; Seung Up Kim
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.